Immune system modulation via cytokine signaling pathways

"Immune system modulation via cytokine signaling pathways" refers not to a single molecular target but rather a complex network involving numerous **cytokines**—small proteins such as interleukins, interferons, tumor necrosis factors—and their corresponding **receptors** on immune cells. These molecules orchestrate the activation, differentiation, proliferation, survival, and apoptosis of various immune cell types through tightly regulated intracellular cascades including the JAK/STAT and NF‑κB pathways. Dysregulation within these networks is implicated in many diseases including autoimmune disorders (such as rheumatoid arthritis), chronic inflammation (like IBD), infections, cancer progression or suppression depending on context. Therapeutic strategies often focus on blocking specific pro-inflammatory cytokines or modulating key nodes within these signal transduction cascades using monoclonal antibodies or small-molecule inhibitors. However, because this entry describes an entire class of biological processes rather than a discrete druggable entity like a receptor or enzyme subunit—and encompasses multiple targets—it is not considered a canonical therapeutic target itself but rather an umbrella term covering many validated targets within its scope.[1][2][3][4] This entry should be flagged as incorrect for structured database purposes because it does not refer to one specific molecule/receptor but instead describes an entire family/network/pathway.

Other names

Cytokine signalingCytokine networkCytokine-mediated immune modulationImmune cell cytokine signaling

Blockade of pro-inflammatory cytokines or their receptors to reduce inflammation and immune activation Modulation of downstream intracellular pathways such as JAK/STAT and NF‑κB to alter gene expression in target cells